You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ONC Award Disclosure
Oyler John · SEC Form 4 · Filed Jun 15, 2026
Award
Calculated transaction value
$0
Oyler John Chief Executive Officer
ONC
Transaction date
Jun 11, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 4 days later
ONC daily price context
Close on/before transaction
$260.27
Jun 11, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Share Option (Right to Buy) on Ordinary Shares
- Quantity / price
- 344,669 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001042047-26-000005
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$501.35K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Beone Medicines Ltd. ONC | Award | Jun 11, 2026 | $0 |
| Beone Medicines Ltd. ONC | Sale | Jun 11, 2026 | $189.87K |
| Beone Medicines Ltd. ONC | Sale | Jun 11, 2026 | $221.27K |
| Beone Medicines Ltd. ONC | Sale | Jun 11, 2026 | $51.66K |
| Beone Medicines Ltd. ONC | Sale | Jun 11, 2026 | $38.56K |
| Beone Medicines Ltd. ONC Current | Award | Jun 11, 2026 | $0 |